Post #6642

💻OpenAI introduced GPT-Rosalind. A frontier reasoning model specifically architected for the life sciences, focusing heavily on biology, drug discovery, and translational medicine. Designed to accelerate the historically slow 10-to-15-year drug approval pipeline, Rosalind is optimized for complex scientific workflows. It features significantly enhanced capabilities in protein and chemical reasoning, genomics analysis, and the autonomous use of highly specialized scientific tools. Source. @aipost🏴